NKGen Biotech Stock (NYSE:GFOR)


OwnershipFinancialsChart

Previous Close

$7.90

52W Range

$6.56 - $12.88

50D Avg

$10.21

200D Avg

$10.18

Market Cap

$86.10M

Avg Vol (3M)

$116.87K

Beta

0.03

Div Yield

-

GFOR Company Profile


Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in The Woodlands, Texas.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NYSE

ADR

-

Country

US

Employees

-

IPO Date

Jul 13, 2021

Website

GFOR Performance


GFOR Financial Summary


Dec 22Dec 21
Revenue--
Operating Income$-2.74M-
Net Income$4.55M-
EBITDA$-10.47M-
Basic EPS$0.21-
Diluted EPS$0.21-

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison


TickerCompany
ERESAbacus Life, Inc.
LCAAL Catterton Asia Acquisition Corp
DHACDigital Health Acquisition Corp.
FXCOFinancial Strategies Acquisition Corp.
VMCAValuence Merger Corp. I